CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823929248
- Phone
- 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-13 | William Arsani Director | Sale | −345,000 | $5.25 | $1.8M | 2,655,000 |
| 2025-08-13 | William Arsani Director | Sale | −217,627 | $5.25 | $1.1M | 1,000,000 |
| 2024-12-18 | Prasad Deepa Director | Sale | −3,806 | $6.27 | $24K | 20,000 |
| 2024-08-09 | William Arsani Director | Sale | −814,874 | $4.25 | $3.5M | 0 |
| 2022-03-22 | Xu Stella Director | Sale | −1,455 | $18.63 | $27K | 4,129,950 |
| 2022-03-21 | Xu Stella Director | Sale | −24,000 | $19.01 | $456K | 4,131,405 |
| 2022-03-18 | Xu Stella Director | Sale | −552,225 | $19.04 | $10.5M | 4,168,605 |
| 2022-03-18 | Xu Stella Director | Sale | −13,200 | $20.34 | $268K | 4,155,405 |
Page 1 of 1 · 8 trades